Carbetocin Short-infusion — Competitive Intelligence Brief

Carbetocin Short-infusion (Carbetocin Short-infusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Oxytocin receptor agonist. Area: Obstetrics.

marketed Oxytocin receptor agonist Oxytocin receptor Obstetrics Small molecule

Target snapshot

Carbetocin Short-infusion (Carbetocin Short-infusion) — University Hospital, Basel, Switzerland. Carbetocin is a synthetic oxytocin analogue that binds to oxytocin receptors to stimulate uterine contractions and promote hemostasis.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Carbetocin Short-infusion TARGET	Carbetocin Short-infusion	University Hospital, Basel, Switzerland	marketed	Oxytocin receptor agonist	Oxytocin receptor
Oxytocin 5 Usp Units In Dextrose 5%	OXYTOCIN	Fresenius Kabi	marketed	Adrenocorticotropic Hormone [EPC]	Oxytocin receptor	1980-01-01
Placebo then intranasal oxytocin	Placebo then intranasal oxytocin	MacDonald, Kai, M.D.	marketed	Neuropeptide	Oxytocin receptor (OXTR)
Standard Dose Synthetic Pitocin	Standard Dose Synthetic Pitocin	Weill Medical College of Cornell University	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Oxytocin versus oxytocin-ergometrine	Oxytocin versus oxytocin-ergometrine	Hadassah Medical Organization	marketed	Uterotonic agent	Oxytocin receptor (OXTR); ergometrine acts on alpha-adrenergic and serotonin receptors
Oxytocin (High dose)	Oxytocin (High dose)	The University of Texas Medical Branch, Galveston	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)
Carbetocin bolus	Carbetocin bolus	Ciusss de L'Est de l'Île de Montréal	marketed	Oxytocin receptor agonist	Oxytocin receptor (OXTR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Oxytocin receptor agonist class)

1. Assistance Publique - Hôpitaux de Paris · 2 drugs in this class
2. Ciusss de L'Est de l'Île de Montréal · 2 drugs in this class
3. Stony Brook University · 2 drugs in this class
4. The University of Texas Medical Branch, Galveston · 1 drug in this class
5. University Hospital, Basel, Switzerland · 1 drug in this class
6. Ain Shams Maternity Hospital · 1 drug in this class
7. Weill Medical College of Cornell University · 1 drug in this class
8. KU Leuven · 1 drug in this class
9. Rambam Health Care Campus · 1 drug in this class